Condition: Persistent Cervical HPV16 Infection · Sponsor: Newish Biotech (Wuxi) Co., Ltd.
This is a randomized, double-blind, placebo controlled study to determine the efficacy and safety of NWRD09 in adult women with persistent cervical HPV16 infection.
This description comes directly from the study's public registry record.
Jian Zhao, M.D. · +86-15601199333 · 854496@qq.com
Always discuss trial participation with your own doctor first.
| Peking University First Hospital | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07710703